Edwards Lifesciences completes acquisition of CASMED
Edwards Lifesciences announced completion of its acquisition of CAS Medical Systems, a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring. Edwards paid $2.45 in cash for each common share of CASMED, which equates to an equity value of $100 million. April 18, 2019